WFDC2 and ovarian cancer: Molina and his colleagues have evaluated the sensitivity of HE4 and CA125 as tumor markers in ovarian cancer at an early stage and HE4 has served as a marker with a higher sensitivity, specificity and efficiency than CA125 and ROMA algorithm (Molina et al., 2011).